Pulmonary Vascular Research Institute

What Pulmonary Vascular Research Institute does

The Pulmonary Vascular Research Institute (PVRI) is a UK-registered global medical research charity and membership organization founded in 2006, dedicated to advancing research, education, and patient care in pulmonary vascular disease (PVD) and pulmonary hypertension (PH). The organization operates a portfolio of programmatic assets including the GoDeep Global PH Registry (an international registry collecting standardized clinical data on PH patients), the Pulmonary Hypertension Global Patient Survey (PHGPS), the Innovative Drug Development Initiative (IDDI) with multiple workstreams and regional task forces spanning Central Asia, China, India, Latin America, Southeast Asia, Saudi Arabia, and Sri Lanka, and the peer-reviewed Pulmonary Circulation journal published in partnership with John Wiley & Sons. PVRI also hosts an annual international Congress (PVRI 2026 Dublin marking 20 years; PVRI 2027 Bangkok), a Digital Webinar Series, monthly PH Community Calls, and a member directory serving academic researchers, clinicians, early-career professionals, patients, advocates, and industry partners across more than 100 countries.

The underlying technology stack combines a self-serve membership and event platform on pvrinstitute.org, the EventsAir event management system for registration and abstract management, SurveyMonkey for regional surveys, Microsoft Dynamics as a CRM for email analytics, and Vumedi as a trusted partner for distributing recorded educational content. AI is used operationally to generate summaries of webinar and Congress presentations and is featured in member research outputs such as LASSO regularized logistic regression models for PAH clinical worsening prediction and AI-enhanced ECG algorithms for early PH detection.

PVRI's business model is a diversified not-for-profit mix: tiered annual membership subscriptions (USD $15 for LMIC early-career, $60-$160 for high-income country members, $230 for pharma/industry, $2,000 lifetime), event delegate fees for the annual Congress and satellite symposia, corporate sponsorships and exhibition fees from pharma and medical device companies, grants and travel awards funded by the organization and partners such as the Butrous Foundation, and individual donations via the 'Become a Friend of PVRI' programme. The go-to-market motion is community-led and event-driven, leveraging the annual Congress, regional symposia, monthly community calls, and webinars to acquire and retain members, with LinkedIn, X, and Bluesky supporting top-of-funnel awareness. Membership pricing is materially subsidized for low- and middle-income countries, with the early-career LMIC fee recently cut from $50 to $15 to broaden access.

Name

Pulmonary Vascular Research Institute

Legal name

The Pulmonary Vascular Research Institute

Website

https://pvrinstitute.org

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1–10 employees

Short description

The Pulmonary Vascular Research Institute (PVRI) is a UK-registered global medical research charity advancing pulmonary vascular disease research, education, and patient care through the GoDeep PH Registry, the Pulmonary Circulation journal, the IDDI drug development initiative, and an annual international Congress serving clinicians, researchers, and patients worldwide.

Ownership category

akta.pro rank

Headquarters

HQ city

Canterbury

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Fees: Annual membership fees ranging from $15 USD for early career in LMICs to $230 USD for pharma/industry members. Membership is a core revenue stream and open to anyone with active research and/or educational interest in pulmonary vascular disease.
2. Event Delegate Fees: Congress and event registration fees with member discounts. Delegate fees must be paid in full before admittance to PVRI events.
3. Donations and Fundraising: PVRI accepts donations and support through various channels including 'Become a Friend of PVRI' program. The organization is a registered charity in England & Wales.
4. Grants and Sponsorships: PVRI offers grants and sponsorships for early-career professionals and provides travel awards funded by the organization and partners.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

Core offering

PVRI is a global medical research charity that operates a membership organization for clinicians, researchers, and patient advocates in pulmonary vascular disease. It delivers value through an annual international Congress, the peer-reviewed Pulmonary Circulation journal, the GoDeep global PH registry, the PHGPS patient survey, IDDI workstreams and task forces, digital webinars, monthly community calls, and grants/awards for early-career professionals. Membership and event delegate fees, corporate partnerships, donations, and grants fund its operations.

Product overview

PVRI is a global charity and membership organisation dedicated to advancing research, education, and patient care in pulmonary vascular disease. Rather than a unified software product, PVRI offers a portfolio of membership services and programmes centred on its core PVRI Membership Platform, which provides access to a member directory, event discounts, and exclusive resources. Key programmatic offerings include the Pulmonary Circulation Journal (official publication), the PVRI Digital Webinar Series, monthly PH Community Calls, the GoDeep Global PH Registry, the PHGPS patient survey initiative, and IDDI Workstreams and Task Forces covering drug development, clinical trials, imaging, and regional specialisations. PVRI also hosts an Annual Congress (PVRI 2027 Bangkok) and manages a grants and awards programme supporting early-career professionals and LMIC colleagues.

Differentiator

Problem solved

Functional benefit

Brands

• Pulmonary Circulation Journal: PVRI's official journal - an international, peer-reviewed, medical research journal dedicated exclusively to pulmonary circulation and pulmonary vascular disease
• IDDI (Innovative Drug Development Initiative)
• GoDeep Global PH Registry
• PHGPS (Pulmonary Hypertension Global Patient Survey)

Products and services

• PVRI Membership Annual paid membership for healthcare professionals, researchers, and patient advocates working in pulmonary vascular disease, with tiered pricing by career stage and country income classification. Benefits include delegate-fee discounts, award and travel-grant eligibility, access to member-only educational resources and the member directory, priority event booking, 10% discount on Pulmonary Circulation publication fees, and voting/nomination rights.
• Pulmonary Circulation Journal
• PVRI Annual Congress
• IDDI (Innovative Drug Development Initiative) Workstreams and Task Forces
• GoDeep Global PH Registry
• Pulmonary Hypertension Global Patient Survey (PHGPS)
• PVRI Digital Webinar Series
• PVRI Abstract and Travel Awards Programme
• Corporate Partnerships Programme

Quantifiable outcome

• PVRI 2027 Bangkok offering £36,000 in abstract and travel awards
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability10 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Merck (MSD outside US)coreStrategic or Co-development Partner · 22 June 2026Joan Zhang, Senior Director, Global Medical Excellence at Merck, joins the PVRI IDDI (Innovative Drug Development Initiative) leadership team, bringing 30+ years of PH, cardiology, and medical affairs experience. She has held leadership roles at United Therapeutics, Acceleron Pharma, and Merck, leading global medical affairs teams and MSL organizations.
• United Therapeutics CorporationcoreStrategic or Co-development PartnerGil Golden from United Therapeutics serves on the IDDI leadership team alongside Luke Howard, Joan Zhang, and Sandeep Sahay. IDDI is a global forum for open discussion, collaboration, and progress in PH drug development.
• Houston Methodist HospitalcoreStrategic or Co-development PartnerSandeep Sahay from Houston Methodist Hospital serves on the IDDI leadership team, contributing clinical expertise to PH drug development initiatives.
• Imperial College Healthcare NHS TrustcoreStrategic or Co-development PartnerLuke Howard from Imperial College Healthcare NHS Trust serves on the IDDI leadership team, providing academic clinical perspective to drug development collaboration.
• Butrous FoundationcoreStrategic or Co-development PartnerThe Butrous Foundation partners with PVRI to sponsor the Young Investigator Award, recognizing excellence in PH research among early-career professionals.
• Amari Bangkok Hotel & Conference CentreminorOthersOfficial venue for PVRI 2027 Bangkok Congress, providing conference facilities and accommodation for the January 2027 event.
• John Wiley & Sons InccoreStrategic or Co-development PartnerPublisher of Pulmonary Circulation journal through their Research Exchange Review system, facilitating manuscript submissions and peer review processes.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Market position

Strengths4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/pvri
• LinkedInlinkedin.com/company/pulmonary-vascular-research-institute
• Facebookfacebook.com/pulmonvasc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pulmonary Vascular Research Institute